About
Sangamo Therapeutics Inc (NASDAQ:SGMO) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
Mar 19 2026
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
Mar 9 2026
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
Feb 3 2026
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
Feb 3 2026
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
Financials
Revenue
$39.55 M
Market Cap
$124.32 M
EPS
-0.44
Google Übersetzer